Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Prospective Observational Study to Evaluate the Safety and Efficacy for Levacalm Tab. Versus Valsartan/Amlodipine Combination Therapy in Patient With Essential Hypertension

NCT02415192 is registered in ClinicalTrials.gov with LG Life Sciences as lead sponsor.

NCT NCT02415192
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02415192 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Prospective Observational Study to Evaluate the Safety and Efficacy for Levacalm Tab. Versus Valsartan/Amlodipine Combination Therapy in Patient With Essential Hypertension
Lead sponsor
LG Life Sciences
Phase
Observational
Overall status
Unknown status
Start date
July 31, 2014
Completion date
November 30, 2016
Enrollment
2,001 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lower leg edema, orthostatic hypertension